The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Automated Medication Compounding System Market Research Report 2024
Synopsis
Pharmacy automation is the mechanization or automation of tasks and processes performed in pharmacy or other health care settings. It includes process like medication dispensing, packaging, labeling, storage and retrieval systems and table top counters. The pharmacy automation not only streamline pharmacy workflow and reduce the risk of errors, they also enable hospitals to refocus pharmacy staff on direct patient-care activities. Automated medication compounding system is a kind of pharmacy automation, which is used for medicine compounding.
The global Automated Medication Compounding System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Automated Medication Compounding System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Medication Compounding System.
Report Scope
The Automated Medication Compounding System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automated Medication Compounding System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated Medication Compounding System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Baxter International
TOSHO
Takazono
Omnicell
YUYAMA
Swisslog
Willach Group
Innovation
Parata
TCGRx
ScriptPro
Talyst
Cerner
Kirby Lester
Segment by Type
Semi Automatic
Fully Automatic
Segment by Application
Inpatient Pharmacy
Outpatient Pharmacy
Retail Pharmacy
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automated Medication Compounding System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automated Medication Compounding System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pharmacy automation is the mechanization or automation of tasks and processes performed in pharmacy or other health care settings. It includes process like medication dispensing, packaging, labeling, storage and retrieval systems and table top counters. The pharmacy automation not only streamline pharmacy workflow and reduce the risk of errors, they also enable hospitals to refocus pharmacy staff on direct patient-care activities. Automated medication compounding system is a kind of pharmacy automation, which is used for medicine compounding.
The global Automated Medication Compounding System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Automated Medication Compounding System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Automated Medication Compounding System.
Report Scope
The Automated Medication Compounding System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Automated Medication Compounding System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Automated Medication Compounding System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Baxter International
TOSHO
Takazono
Omnicell
YUYAMA
Swisslog
Willach Group
Innovation
Parata
TCGRx
ScriptPro
Talyst
Cerner
Kirby Lester
Segment by Type
Semi Automatic
Fully Automatic
Segment by Application
Inpatient Pharmacy
Outpatient Pharmacy
Retail Pharmacy
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Automated Medication Compounding System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Automated Medication Compounding System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Automated Medication Compounding System Market Overview
1.1 Product Overview and Scope of Automated Medication Compounding System
1.2 Automated Medication Compounding System Segment by Type
1.2.1 Global Automated Medication Compounding System Market Value Comparison by Type (2024-2030)
1.2.2 Semi Automatic
1.2.3 Fully Automatic
1.3 Automated Medication Compounding System Segment by Application
1.3.1 Global Automated Medication Compounding System Market Value by Application: (2024-2030)
1.3.2 Inpatient Pharmacy
1.3.3 Outpatient Pharmacy
1.3.4 Retail Pharmacy
1.3.5 Other
1.4 Global Automated Medication Compounding System Market Size Estimates and Forecasts
1.4.1 Global Automated Medication Compounding System Revenue 2019-2030
1.4.2 Global Automated Medication Compounding System Sales 2019-2030
1.4.3 Global Automated Medication Compounding System Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Automated Medication Compounding System Market Competition by Manufacturers
2.1 Global Automated Medication Compounding System Sales Market Share by Manufacturers (2019-2024)
2.2 Global Automated Medication Compounding System Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Automated Medication Compounding System Average Price by Manufacturers (2019-2024)
2.4 Global Automated Medication Compounding System Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Automated Medication Compounding System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automated Medication Compounding System, Product Type & Application
2.7 Automated Medication Compounding System Market Competitive Situation and Trends
2.7.1 Automated Medication Compounding System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automated Medication Compounding System Players Market Share by Revenue
2.7.3 Global Automated Medication Compounding System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automated Medication Compounding System Retrospective Market Scenario by Region
3.1 Global Automated Medication Compounding System Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Automated Medication Compounding System Global Automated Medication Compounding System Sales by Region: 2019-2030
3.2.1 Global Automated Medication Compounding System Sales by Region: 2019-2024
3.2.2 Global Automated Medication Compounding System Sales by Region: 2025-2030
3.3 Global Automated Medication Compounding System Global Automated Medication Compounding System Revenue by Region: 2019-2030
3.3.1 Global Automated Medication Compounding System Revenue by Region: 2019-2024
3.3.2 Global Automated Medication Compounding System Revenue by Region: 2025-2030
3.4 North America Automated Medication Compounding System Market Facts & Figures by Country
3.4.1 North America Automated Medication Compounding System Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Automated Medication Compounding System Sales by Country (2019-2030)
3.4.3 North America Automated Medication Compounding System Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Automated Medication Compounding System Market Facts & Figures by Country
3.5.1 Europe Automated Medication Compounding System Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Automated Medication Compounding System Sales by Country (2019-2030)
3.5.3 Europe Automated Medication Compounding System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automated Medication Compounding System Market Facts & Figures by Country
3.6.1 Asia Pacific Automated Medication Compounding System Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Automated Medication Compounding System Sales by Country (2019-2030)
3.6.3 Asia Pacific Automated Medication Compounding System Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Automated Medication Compounding System Market Facts & Figures by Country
3.7.1 Latin America Automated Medication Compounding System Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Automated Medication Compounding System Sales by Country (2019-2030)
3.7.3 Latin America Automated Medication Compounding System Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Automated Medication Compounding System Market Facts & Figures by Country
3.8.1 Middle East and Africa Automated Medication Compounding System Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Automated Medication Compounding System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Automated Medication Compounding System Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Automated Medication Compounding System Sales by Type (2019-2030)
4.1.1 Global Automated Medication Compounding System Sales by Type (2019-2024)
4.1.2 Global Automated Medication Compounding System Sales by Type (2025-2030)
4.1.3 Global Automated Medication Compounding System Sales Market Share by Type (2019-2030)
4.2 Global Automated Medication Compounding System Revenue by Type (2019-2030)
4.2.1 Global Automated Medication Compounding System Revenue by Type (2019-2024)
4.2.2 Global Automated Medication Compounding System Revenue by Type (2025-2030)
4.2.3 Global Automated Medication Compounding System Revenue Market Share by Type (2019-2030)
4.3 Global Automated Medication Compounding System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Automated Medication Compounding System Sales by Application (2019-2030)
5.1.1 Global Automated Medication Compounding System Sales by Application (2019-2024)
5.1.2 Global Automated Medication Compounding System Sales by Application (2025-2030)
5.1.3 Global Automated Medication Compounding System Sales Market Share by Application (2019-2030)
5.2 Global Automated Medication Compounding System Revenue by Application (2019-2030)
5.2.1 Global Automated Medication Compounding System Revenue by Application (2019-2024)
5.2.2 Global Automated Medication Compounding System Revenue by Application (2025-2030)
5.2.3 Global Automated Medication Compounding System Revenue Market Share by Application (2019-2030)
5.3 Global Automated Medication Compounding System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Corporation Information
6.1.2 BD Description and Business Overview
6.1.3 BD Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BD Automated Medication Compounding System Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Baxter International
6.2.1 Baxter International Corporation Information
6.2.2 Baxter International Description and Business Overview
6.2.3 Baxter International Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Baxter International Automated Medication Compounding System Product Portfolio
6.2.5 Baxter International Recent Developments/Updates
6.3 TOSHO
6.3.1 TOSHO Corporation Information
6.3.2 TOSHO Description and Business Overview
6.3.3 TOSHO Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TOSHO Automated Medication Compounding System Product Portfolio
6.3.5 TOSHO Recent Developments/Updates
6.4 Takazono
6.4.1 Takazono Corporation Information
6.4.2 Takazono Description and Business Overview
6.4.3 Takazono Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takazono Automated Medication Compounding System Product Portfolio
6.4.5 Takazono Recent Developments/Updates
6.5 Omnicell
6.5.1 Omnicell Corporation Information
6.5.2 Omnicell Description and Business Overview
6.5.3 Omnicell Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Omnicell Automated Medication Compounding System Product Portfolio
6.5.5 Omnicell Recent Developments/Updates
6.6 YUYAMA
6.6.1 YUYAMA Corporation Information
6.6.2 YUYAMA Description and Business Overview
6.6.3 YUYAMA Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 YUYAMA Automated Medication Compounding System Product Portfolio
6.6.5 YUYAMA Recent Developments/Updates
6.7 Swisslog
6.6.1 Swisslog Corporation Information
6.6.2 Swisslog Description and Business Overview
6.6.3 Swisslog Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Swisslog Automated Medication Compounding System Product Portfolio
6.7.5 Swisslog Recent Developments/Updates
6.8 Willach Group
6.8.1 Willach Group Corporation Information
6.8.2 Willach Group Description and Business Overview
6.8.3 Willach Group Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Willach Group Automated Medication Compounding System Product Portfolio
6.8.5 Willach Group Recent Developments/Updates
6.9 Innovation
6.9.1 Innovation Corporation Information
6.9.2 Innovation Description and Business Overview
6.9.3 Innovation Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Innovation Automated Medication Compounding System Product Portfolio
6.9.5 Innovation Recent Developments/Updates
6.10 Parata
6.10.1 Parata Corporation Information
6.10.2 Parata Description and Business Overview
6.10.3 Parata Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Parata Automated Medication Compounding System Product Portfolio
6.10.5 Parata Recent Developments/Updates
6.11 TCGRx
6.11.1 TCGRx Corporation Information
6.11.2 TCGRx Automated Medication Compounding System Description and Business Overview
6.11.3 TCGRx Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.11.4 TCGRx Automated Medication Compounding System Product Portfolio
6.11.5 TCGRx Recent Developments/Updates
6.12 ScriptPro
6.12.1 ScriptPro Corporation Information
6.12.2 ScriptPro Automated Medication Compounding System Description and Business Overview
6.12.3 ScriptPro Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.12.4 ScriptPro Automated Medication Compounding System Product Portfolio
6.12.5 ScriptPro Recent Developments/Updates
6.13 Talyst
6.13.1 Talyst Corporation Information
6.13.2 Talyst Automated Medication Compounding System Description and Business Overview
6.13.3 Talyst Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Talyst Automated Medication Compounding System Product Portfolio
6.13.5 Talyst Recent Developments/Updates
6.14 Cerner
6.14.1 Cerner Corporation Information
6.14.2 Cerner Automated Medication Compounding System Description and Business Overview
6.14.3 Cerner Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Cerner Automated Medication Compounding System Product Portfolio
6.14.5 Cerner Recent Developments/Updates
6.15 Kirby Lester
6.15.1 Kirby Lester Corporation Information
6.15.2 Kirby Lester Automated Medication Compounding System Description and Business Overview
6.15.3 Kirby Lester Automated Medication Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Kirby Lester Automated Medication Compounding System Product Portfolio
6.15.5 Kirby Lester Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automated Medication Compounding System Industry Chain Analysis
7.2 Automated Medication Compounding System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automated Medication Compounding System Production Mode & Process
7.4 Automated Medication Compounding System Sales and Marketing
7.4.1 Automated Medication Compounding System Sales Channels
7.4.2 Automated Medication Compounding System Distributors
7.5 Automated Medication Compounding System Customers
8 Automated Medication Compounding System Market Dynamics
8.1 Automated Medication Compounding System Industry Trends
8.2 Automated Medication Compounding System Market Drivers
8.3 Automated Medication Compounding System Market Challenges
8.4 Automated Medication Compounding System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
